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The aim of this work was to study the toxin types of Clostridium difficile isolates originating from different
parts of Hungary. A PCR method was used for amplification of the two major toxin genes and the binary toxin
gene and to detect the deletion or insertion in the 3 end of the toxin A gene. The findings were compared with
the results of cytotoxicity assays on the HeLa cell line. One hundred twelve isolates were tested; the toxin A and
toxin B genes were detected in 79 strains by the PCR method. All of the isolates that were positive by the PCR
method were also positive by the cytotoxicity assay. All of the other strains (n  33) were negative for the toxin
A and toxin B genes; in these cases, cytopathic effects on the cell line were not observed. No tcdA-negative and
tcdB-positive isolates were found by the PCR method. In two cases, the presence of a binary toxin gene was
observed by PCR; both isolates that were isolated from diarrheal feces carried the tcdA and tcdB genes. No prior
hospitalization had occurred in either case.
Clostridium difficile is an anaerobic, gram-positive, spore-
forming rod. Toxigenic strains are causative agents of antibi-
otic-associated diarrhea, antibiotic-associated colitis, and
pseudomembranous colitis (1, 2). Such strains produce two
major toxins: toxin A (TCDa), a cytotoxic enterotoxin that
induces fluid secretion, and toxin B (TCDb), a cytotoxin. These
toxins cause tissue damage in the intestinal mucosa (3). Both
toxins evoke morphological changes in cell lines such as Vero,
HeLa, and Hep2, but toxin B is a more potent cytotoxin than
toxin A, and cytotoxicity assays therefore mainly detect toxin B.
Toxin A variant strains (tcdA negative, tcdB positive) have
been reported earlier; these strains lack the repeating se-
quences of the tcdA gene. The deletion was detected by PCR
because in this case the amplified fragment differs in length
from the PCR product of reference strain VPI 10463. These
strains are toxin A negative by commercial enzyme immuno-
assay, which detects only the presence of toxin A, giving a
negative result, as the strains are deficient in the portion of
toxin A that is immunodominant; this repeating unit is recog-
nized by the antibodies used in the toxin A-specific detection
kits. In contrast, the cytotoxicity assays are positive because of
the presence of toxin B, which is an effective cytotoxin (6).
Some strains are known to produce actin-specific ADP-ri-
bosyltransferase (CDT) (binary toxin), which is organized ac-
cording to A-B toxin type. CDTa (48 kDa) is an enzymatic
component, and CDTb (94 kDa) is a binding domain that
recognizes the surface receptors of the host cells and mediates
the cell entry of CDTa. Two subunits are encoded by separate
genes: cdtA and cdtB. Actin modified by CDT induces damage
to the actin cytoskeleton and leads to a cytopathic effect on the
cell line (5, 9). Binary toxin-producing strains can be divided
into three main groups: both toxin A and toxin B positive, both
toxin A and toxin B negative, and toxin A negative and toxin B
positive (10). The role of this toxin (particularly if the isolate is
both toxin A and toxin B positive) in gastrointestinal infections
is unclear, but the cytopathic effect on the cell line and the
similarity to other clostridial binary toxins suggest that the
binary toxin of C. difficile can be an additional virulence factor.
In Hungary, the presence of binary toxin-producing C. dif-
ficile strains has not been analyzed so far. Accordingly, we
examined the presence of the cdtA, cdtB, tcdA, and tcdB genes,
the deletion in the 3 end of the toxin A gene, and the cyto-
pathic effect on the HeLa cell line on C. difficile strains origi-
nating from fecal specimens.
Bacterial strains. One hundred twelve isolates of C. difficile
from fecal specimens of both outpatients and inpatients were
examined. These strains were isolated and identified at differ-
ent laboratories in Hungary (the Budapest region, North
Transdanubia, Szolnok [central Hungary], and Szeged [south-
ern Hungary]). Forty-one strains were isolated from inpatients,
38 isolates were from outpatients, and in 33 cases we have not
obtained these data yet. Reference strain VPI 10463 (toxin
type 0) was obtained from the American Type Culture Collec-
tion (Rockville, Md.). Binary toxin-producing control strains
were supplied by Jon Brazier (Anaerobe Reference Unit,
Cardiff, United Kingdom). The strains were grown on anaer-
obic blood agar plates supplemented with 1 mg of vitamin K1
per liter and 0.3 g of cysteine per liter and in brain heart
infusion broth. The cultures were incubated in an anaerobic
chamber (85% N2, 10% CO2, 5% H2; Bactron; Sheldonb Man.
Inc.) for 24 h at 37°C.
Toxin assays. The cultures were centrifuged at 15,300  g
for 5 min, the supernatants were filtered through a 0.22-m-
pore-size membrane (MILLEX-GV), and the filtrate was fro-
zen immediately and kept at20°C until used. HeLa cells were
grown at 37°C in Dulbecco’s modified Eagle’s medium (Sigma,
St. Louis, Mo.) supplemented with 10% heat-inactivated fetal
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bovine serum. Before the cytotoxicity assay, the cell culture
medium was removed and fresh medium was added without
serum. Tenfold dilutions of filtered bacterial culture superna-
tants were inoculated into the wells, and after incubation (at
37°C in 5% CO2 for 24 h) the cytopathic effect was examined.
C. difficile goat antitoxin serum was used for the toxin neutral-
ization test; this antitoxin serum neutralizes both toxin A and
toxin B (8).
PCR assays. A single colony of C. difficile was suspended in
TES buffer (50 mM Tris hydrochloride [pH 8.0], 5 mM EDTA,
50 mM NaCl), and the suspension was heated at 95°C for 10
min and then centrifuged at 15,300  g for 5 min. The se-
quences of the primers used for PCR amplification in this study
are listed in Table 1. NK2 and NK3 were derived from the
nonrepeating sequence of the toxin A gene, while NK104 and
NK105 were from the sequence of the toxin B gene. NK9 and
NK11 were from the repeating sequence of the toxin A gene;
these primers were used to detect the deletion of the 3 end of
the toxin A gene. The reaction mixture (20 l) contained 10
mM Tris-HCl (pH 9.0), 50 mM KCl, 2.5 mM MgCl2, 0.1 g/ml
gelatin, 0.2 mM deoxynucleoside triphosphate, 0.3 U of Taq
DNA polymerase supplied in 10 l of Ready Mix (Sigma), and
0.15 M cdtApos, cdtArev, cdtBpos, and cdtBrev (cdtA and
cdtB PCR) or 45 ng of the NK2, NK3, NK9, NK11, NK104, and
NK105 primers. The reaction mixtures were incubated for 30
(cdtA and cdtB PCR) or 35 (tcdA and tcdB PCR) cycles in a
PCR system (GeneAmp, PCR System 9600; Perkin-Elmer,
Norwalk, Conn.). Gene amplification consisted of denatur-
ation at 94°C for 45 s (cdtA and cdtB) or at 95°C for 20 s (tcdA
and tcdB), annealing at 52°C for 60 s (cdtA and cdtB) or at 62°C
for 120 s (tcdA and tcdB), and extension at 72°C for 120 s (cdtA
and cdtB) (6, 7, 12). PCR products were visualized by running
in 0.8 to 1.5% agarose gels with ethidium bromide (0.5 g/ml)
at 5 V/cm in Tris-borate EDTA buffer (45 mM Tris-borate, 1
mM EDTA). Gels were photographed under UV light with a
Kodak digital camera and analyzed with Kodak 1D 3.5
software.
Detection of toxin A, toxin B, and binary toxin by PCR and
comparison of data obtained with the cytotoxicity assay. One
hundred twelve C. difficile strains were examined; the presence
of the toxin A and toxin B genes was observed in 79 strains, and
morphological changes were demonstrated in the HeLa cell
line. Thirty-three isolates were negative for both the toxin A
and toxin B genes by PCR; none of those 33 isolates caused
morphological damage to HeLa cells either. Eight strains had
a cytotoxicity titer of 101, 36 strains had a cytotoxicity titer of
102, 25 strains had a cytotoxicity titer of 103, and 10 strains
had a cytotoxicity titer of103. Toxin-positive isolates had no
deletions or insertions in the repeating 3 end of the toxin A
gene. Two isolates were detected via the expected 375-bp
(cdtA) and 510-bp (cdtB) DNA fragments by PCR with binary
toxin-specific primer pairs. In both cases, no deletion could be
detected in the 3 end of the tcdA gene with the NK9 and NK11
primer pairs, cytopathic effects on the cell line were observed,
and both the tcdA and tcdB genes were amplified by PCR from
two isolates. Binary toxin-positive, toxin A- and toxin B-nega-
tive strains were not found in this study.
It is known that several Clostridium species may produce
binary toxin; these strains generally cause gastrointestinal dis-
ease. C. spiroforme has been isolated from rabbit enteritis and
human diarrheal feces, and animal enterotoxemia has been
associated with C. perfringens type E (4).
The structure of the C. difficile binary toxin is well known,
but few data are available on the role of this toxin in the
pathogenesis of human gastrointestinal disease; accordingly,
we collected data on the patients in whom the binary toxin-
positive strains were isolated. The first binary toxin-producing
strain was isolated from diarrheal feces of an 8-year-old boy.
He had follicular tonsillitis and therefore received amoxicillin-
clavulanic acid orally. He developed severe diarrheal disease
during the therapy. The family doctor then changed the anti-
biotic therapy to amoxicillin, but the boy did not recover from
the diarrhea. He was admitted to the gastroenterology unit of
the Pal Heim Children’s Hospital in Budapest. Diarrheal feces
collected on the first day of his hospitalization proved positive
for anaerobic, gram-positive, spore-forming rods; the colonies
were irregular, with a rhizoid edge, and were identified as C.
difficile by the RapID 32A test (BioMe´rieux, Marcy l’E´toile,
France). Toxin A was detected by the toxin A test (Oxoid). The
boy received oral metronidazole, and the alternative treatment
was oral Lactobacillus therapy. Confirmed relapses were not
observed after treatment.
TABLE 1. Sequences of oligonucleotide primers used in this studya
Gene Primer Sequence (533) Position Size ofproduct (bp)
cdtA cdtApos TGA ACC TGG AAA AGG TGA TG 507–526 375
cdtArev AGG ATT ATT TAC TGG ACC ATT TG 882–860
cdtB cdtBpos CTT AAT GCA AGT AAA TAC TGA G 368–389 510
cdtBrev AAC GGA TCT CTT GCT TCA GTC 878–858
tcdA NK2 CCC AAT AGA AGA TTC AAT ATT AAG CTT 2479–2505 251
NK3 GGA AGA AAA GAA CTT CTG GCT CAC TCA GGT 2254–2283
tcdA rep NK9 CCA CCA GCT GCA GCC ATA 8043–8060 1,265
NK11 TGA TGC TAA TAA TGA ATC TAA AAT GGT AAC 6795–6824
tcdB NK104 GTG TAG CAA TGA AAG TCC AAG TTT ACG C 2945–2972 203
NK105 CAC TTA GCT CTT TGA TTG CTG CAC CT 3123–3148
a Data from references 6, 7, and 12. rep, repetitive region.












The second binary toxin-producing strain was a fecal isolate
from a 42-year-old woman who likewise suffered from diar-
rhea; the presumed diagnosis was infectious enteritis. She re-
ceived oral sulfamethoxazole-trimethoprim for an upper respi-
ratory tract infection before the appearance of her diarrhea.
Gram-positive, spore-forming rods were isolated from the di-
arrheal feces by using CCFA (cycloserine cefoxitin fructose
agar) medium and were identified as C. difficile, but at that
time no toxin test was performed in the local laboratory. This
isolate was sent to the reference laboratory (Szeged, Hungary)
for toxin detection, where the presence of tcdA, tcdB, cdtA, and
cdtB was detected by PCR, and cytotoxic effects on the HeLa
cell line were tested. After the termination of antibiotic treat-
ment, the condition of the patient improved without specific
therapy against C. difficile, and no relapse was observed. In this
case history too, no prior hospitalization had taken place.
In an earlier study (13), 65 C. difficile strains were isolated in
the Szeged laboratory from patients in different wards in order
to investigate the presence of toxins A and B, and ribotyping
was used for epidemiological purposes in collaboration with
the Anaerobe Reference Laboratory in Cardiff, United King-
dom, where the largest collection of data on different ribotypes
of C. difficile is to be found at present. Fifteen different ri-
botypes were detected, including one new type with two iso-
lates. No binary toxin-producing, toxin A-negative and toxin
B-positive strains were found among these C. difficile isolates
causing hospital-acquired diarrhea. In the present study, tcdA-
negative and tcdB-positive strains were not detected by PCR
among 112 isolates, but 2 strains that were isolated from com-
munity-acquired diarrhea carried the binary toxin gene. In
these cases tcdA and tcdB were detected by PCR and the
cytotoxicity assays were also positive. It seems that in Hungary
the prevalence of binary toxin-producing strains differs consid-
erably from the data in international studies; this discrepancy
may be explained by differences in the number of isolates
studied or the geographical distribution of different clones (9,
11, 12). When the number of strains studied was low, the
occurrence of binary toxin-positive isolates was high (ranging
from 8.3 to 23.5%); when large C. difficile collections were
examined, the estimated prevalence was 1.6% (Japan) to 5.5%
(Anaerobe Reference Unit collection) (11). Interestingly, both
of the binary toxin-positive isolates observed during the
present survey originated from outpatients with no previous
history of hospitalization, but the pathogenic role of binary
toxin could not be determined because of the presence of toxin
A and toxin B. Molecular characterization of toxin variant
strains is widely used, but the role of binary toxin in C. difficile-
associated disease is still unclear. Two binary toxin-positive
and toxin A- and toxin B-positive isolates suggest that this
pathogen may be responsible for certain cases of community-
acquired diarrhea. We therefore regard toxin detection in di-
arrheal feces in the community and further epidemiological
examinations of Hungarian strains to be of high importance.
The characterization of binary toxin-positive isolates and fur-
ther patients from whom binary toxin-positive strains can be
isolated may support the pathogenic role of binary toxin.
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